Sanne L Nijhof

Dr. Sanne L Nijhof

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2012 in The Lancet
Verified
Journal Article
Closed access
SNSanne L Nijhof
Sanne L Nijhof
GBGijs Bleijenberg
Gijs Bleijenberg
CUCuno Spm Uiterwaal
Cuno Spm Uiterwaal
JKJan Ll Kimpen
Jan Ll Kimpen
EPElise M van de Putte
Elise M van de Putte

1 May 2011 in Pediatrics
Verified
Journal Article
Closed access
PDF file
SNSanne L Nijhof
Sanne L Nijhof
KMKimberley Maijer
Kimberley Maijer
GBGijs Bleijenberg
Gijs Bleijenberg
CUCuno S. P. M. Uiterwaal
Cuno S. P. M. Uiterwaal
JKJan L. L. Kimpen
Jan L. L. Kimpen
EPElise M. van de Putte
Elise M. van de Putte
OBJECTIVE: To determine nationwide general practitioner (GP)-diagnosed prevalence and pediatrician–diagnosed incidence rates of adolescent chronic fatigue syndrome (CFS), and to assess CFS morbidity. DESIGN AND SETTING: We collected data from a cross-sectional national sample among GPs and prospective registration of new patients with CFS in all pediatric hospital departments in the Netherlands. PATIENTS AND METHODS: Study participants were adolescents aged 10 to 18 years. A representative sample of GPs completed questionnaires on the prevalence of CFS in their adolescent patients. Pediatric hospital departments prospectively reported new cases of CFS in adolescent patients. For every new reported case, a questionnaire was sent to the reporting pediatrician and the reported patient to assess CFS morbidity. Prevalence was estimated through the data from GP questionnaires and incidence was estimated on the basis of cases newly reported by pediatricians from January to December 2008. RESULTS: Prevalence was calculated as 111 per 100 000 adolescents and incidence as 12 per 100 000 adolescents per year. Of newly reported patients with CFS, 91% scored at or above cutoff points for severe fatigue and 93% at or above the cutoff points for physical impairment. Forty-five percent of patients with CFS reported >50% school absence during the previous 6 months. CONCLUSIONS: Clinically diagnosed incidence and prevalence rates show that adolescent CFS is uncommon compared with chronic fatigue. The primary adverse impact of CFS is extreme disability associated with considerable school absence.

1 April 2014 in Psychoneuroendocrinology
Verified
Journal Article
Closed access
SNSanne L Nijhof
Sanne L Nijhof
JRJuliette M.T.M. Rutten
Juliette M.T.M. Rutten
CUCuno S.P.M. Uiterwaal
Cuno S.P.M. Uiterwaal
GBGijs Bleijenberg
Gijs Bleijenberg
JKJan L.L. Kimpen
Jan L.L. Kimpen
EPElise van de Putte
Elise van de Putte

1 June 2013 in Pediatrics
Verified
Journal Article
Open access
PDF file
SNSanne L Nijhof
Sanne L Nijhof
LPLoudy P. Priesterbach
Loudy P. Priesterbach
CUCuno S. P. M. Uiterwaal
Cuno S. P. M. Uiterwaal
GBGijs Bleijenberg
Gijs Bleijenberg
JKJan L. L. Kimpen
Jan L. L. Kimpen
EPElise M. van de Putte
Elise M. van de Putte
OBJECTIVE: Cognitive behavioral therapy (CBT) is known to be an effective treatment of adolescents with chronic fatigue syndrome (CFS), but its availability is limited. Fatigue in Teenagers on the Internet (FITNET), an Internet-based CBT program for adolescents with CFS, has been developed as an alternative to face-to-face CBT. Recently, its short-term effectiveness has been proven in a randomized clinical trial. Here we aimed to assess the long-term outcome of CFS in adolescents after FITNET treatment and after usual care. In addition, factors related to recovery at long-term follow-up (LTFU) for adolescents treated with the FITNET program were investigated. METHODS: The study was an LTFU of participants of the FITNET trial. Data were completed for 112 (88.2%) of 127 approached FITNET study participants. Primary outcomes were fatigue severity (Checklist Individual Strength–20), physical functioning (87-item Child Health Questionnaire), and school/work attendance. RESULTS: After a mean follow-up of 2.7 years, 66 (58.9%) adolescents had recovered from CFS. Most adolescents who recovered directly after treatment with FITNET were still recovered at LTFU. At LTFU there was no difference between the recovery rates for the different treatment strategies (original randomization: FITNET [64%] versus any form of usual care [52.8%]). Per additional month of “pretreatment disease duration,” the odds for recovery were 4% lower (odds ratio: 0.96; 95% confidence interval: 0.93–0.99; P = .016), and per added point on “focus on bodily symptoms” (Body Consciousness Scale) of the mother (0–20 points) the odds for recovery were 11% lower (odds ratio: 0.89; 95% confidence interval: 0.80–0.99; P = .029). CONCLUSIONS: The short-term effectiveness of Internet-based CBT on adolescent CFS is maintained at LTFU. At LTFU, usual care led to similar recovery rates, although these rates were achieved at a slower pace.

21 December 2015 in Arthritis Care & Research
Verified
Journal Article
Closed access
PDF file
SNSanne L Nijhof
Sanne L Nijhof
EPElise M. van de Putte
Elise M. van de Putte
NWNico M. Wulffraat
Nico M. Wulffraat
SNSanne L. Nijhof
Sanne L. Nijhof

12 June 2013 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
CWCharlotte L. Werker
Charlotte L. Werker
SNSanne L Nijhof
Sanne L Nijhof
EPElise van de Putte
Elise van de Putte